Search arXivSearch

arXiv · 1205.2109

An Analysis of the Prevalence of Pneumonia for Children under 12 Year Old in Tawau General Hospital, Malaysia

Abstract

Pneumonia is one of the serious illnesses, which involves lung infection specifically alveoli. Nearly 40,000 to 70,000 people die each year in United State because of pneumonia. Therefore, it is not a surprise that pneumonia is one of the most critical illnesses for children under 12 years old in many parts of the world, including Malaysia and particularly in Tawau, Sabah, Malaysia. The objectives of this study are: to develop a summary on the prevalence of pneumonia in Tawau General Hospital, to analyze the best practice to prevent this illness and lastly to determine an overview of which area that is widely affected by pneumonia. The results can assist doctors and the government to take major precautions and preventive measures efficiently to the full extent. This paper presents a descriptive analysis of the data, which are retrieved from the medical reports at the Tawau General Hospital. Through the findings, pneumonia is widely spread among young children under 12 years old. There are more than one major factor that leads to this critical illness, such as family background, genetic and environment. Therefore, the government, doctors and parents should take major steps to prevent children suffering from pneumonia.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Suliadi F. Sufahani, Siti N. A. Mohd Razali, Mohammad F. Mormin, Azme Khamis. 2012-05-09. An Analysis of the Prevalence of Pneumonia for Children under 12 Year Old in Tawau General Hospital, Malaysia. https://arxiv.org/abs/1205.2109

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

Geospatial Foundation Models Capture Health-Relevant Dimensions of Place Beyond Conventional Social Risk Indices

Area-based social risk indices summarize residents' socioeconomic conditions but incompletely capture physical features of place that may affect health. We evaluated whether numerical representations of physical place produced by four geospatial foundation model families from 2022 satellite data explained residual variance in tract-level associations between the Area Deprivation Index, Social Deprivation Index, and Social Vulnerability Index with health outcomes. We used LightGBM to predict variables from the American Community Survey and 40 chronic disease and health-behavior outcomes from CDC PLACES across 82,646 census tracts in the contiguous United States, evaluating performance across 10 held-out states. Among survey variables, models were moderately predictive of some variables including housing type (R-squared up to 0.54) but weak for disability, unemployment, and income disparity. For health outcomes, models explained up to 54% of variance left unexplained by social risk indices, with the largest gains for annual checkups, arthritis, and high blood pressure. Mean total variance explained by geospatial foundation models across the 40 health-related outcomes increased from 0.31 in the smallest tract-size decile to 0.39 in the largest. Geospatial foundation models capture health-relevant features of place not represented by conventional social risk indices and may usefully augment them in epidemiological analyses.

stat.AP

Transporting summary measures of relative effects from randomised trials to the treated patient population: an application to breast cancer endocrine therapy

Randomised trials often report relative treatment effects, such as risk ratios and hazard ratios, for trial populations. Clinical decision-making, however, often benefits from estimates of absolute treatment effects in the population eligible for treatment. Trial participants may not represent this target population well, and restrictions on access to individual participant trial data can further complicate absolute effect estimation. Routine care data are often representative of the target population but may be subject to uncontrolled confounding. We consider estimation of the average treatment effect on the treated (ATT), an absolute measure, by combining a representative sample of treated routine care patients with summary measures (i.e., estimated risk or hazard ratios) from either a randomised trial or a meta-analysis of trials. Under marginal or conditional transportability assumptions, the ATT is shown to be identifiable. The implications of collapsibility of the effect measure on transportability are discussed, and plug-in estimators of the ATT are presented. Simulation studies are used to assess finite sample performance of the estimators in a range of settings. The proposed methods are applied to estimate the ATT of endocrine therapy on 15-year breast cancer mortality using results from a meta-analysis of randomised trials and England's National Disease Registration Service.

stat.AP

Overcoming Model Misspecification in Bayesian Inference of Molecular Signalling Networks

Bayesian inference of molecular signalling networks usually relies on tractability of the marginal likelihood, enabling the set of possible networks to be efficiently explored. As such, linear models with independent errors and conjugate priors are routinely used. However, the dynamics of molecular signalling are nonlinear, and relevant confounders are often unobserved; failure to account for these complexities will almost certainly lead to over-confident inferences in the standard Bayesian framework. To confront this reality, we develop a post-Bayesian approach to inference of molecular signalling networks, guided by the principle that uncertainty should not vanish when the statistical model is misspecified, even in the infinite-data limit. Technically, we extend the predictively-oriented (PrO) posterior of McLatchie et al. (2025) to the setting of latent variable models, empirically investigating the properties of PrO posteriors in the challenging network inference context.

stat.AP